Search results
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine ...
WFRV 5 Green Bay· 16 hours agoThe terms of the agreement include: a co-exclusive license to co-commercialize Novavax's current stand-alone adjuvanted COVID-19 vaccine worldwide (except ...
ESCMID 2024: Cutting-edge vaccines in development for a healthier tomorrow
Clinical Trials Arena via Yahoo Finance· 1 week agoThe R21/Matrix-M vaccine, developed by Oxford University and the Serum Institute of India,...